Starting July 1, Medicare will cover three Ozempic-style weight-loss medications for $50 per month through a new temporary ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. More accessible weight loss medication is on the horizon after ...

Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage for ...

Tirzepatide (Zepbound) is not in shortage for now, but the weight loss drug has remained inaccessible to people without insurance coverage who can't afford to pay out of pocket. Now, its manufacturer, ...

INDIANAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Today Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...

Mounjaro and Zepbound are two brand-name glucagon-like peptide-1 (GLP-1) medications manufactured by Eli Lilly. Although they contain the same active ingredient, tirzepatide, and may affect blood ...

Ro said it will offer a "complete end-to-end" experience on a single platform and app, allowing eligible patients to receive a diagnosis and a prescription for Zepbound and have vials of the drug ...

Eli Lilly (LLY) has added a new telehealth partner to expand access to single-dose vials of its blockbuster weight loss drug Zepbound. Ro is joining other telehealth platforms and Amazon Pharmacy ...